Omap One Inj / Omap Plus One Inj (TPN)

Omap One Inj / Omap Plus One Inj (TPN)
Product Description

Omap One Peri is a three-chamber peripheral parenteral nutrition solution designed for patients who cannot receive sufficient nutrition orally or enterally. It provides essential nutrients, including glucose, amino acids, and lipids, to support energy needs and nutritional balance. The product can be administered through a peripheral or central vein under appropriate medical supervision. Omap Plus One is a three-chamber parenteral nutrition solution designed to provide balanced nutritional support for patients who cannot receive adequate nutrition orally or enterally. It contains glucose, amino acids, and lipids, with a higher proportion of omega-3 fatty acids to help support balanced fat nutrition. It is administered under medical supervision.

HK inno.N Corporation

  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2020
Company types
Pharmaceutical company

HK inno.N Corporation

  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2020
Company types
Pharmaceutical company

More Products from HK inno.N Corporation (6)

  • Exone-R Tab. (Valsartan/Amlodipine/Rosuvastatin)

    Product Exone-R Tab. (Valsartan/Amlodipine/Rosuvastatin)

    Exone-R is a fixed-dose triple combination therapy for patients with hypertension and dyslipidemia. It combines Valsartan and Amlodipine to help control blood pressure, along with Rosuvastatin to manage cholesterol levels. By addressing both cardiovascular risk factors in a single tablet, Exone-R supports ...
  • Tegoprazan

    Product Tegoprazan

    Tegoprazan is a novel patented Potassium-Competitive Acid Blocker (P-CAB) which alleviates the limitations of the historical Proton Pump Inhibitors (PPIs) and of other competing P-CABs. 

    Tegoprazan's competitive advantages have been demonstrated via Phase 3 clinical studies conducted in Korea a...
  • Atomet XR Tab. (Atorvastatin + Metformin)

    Product Atomet XR Tab. (Atorvastatin + Metformin)

    Fixed Dose Combination drug, indicated for Type2 Diabetes with Hyperlipidemia with Clinical trials phase Ⅰ & Ⅲ

  • Calmtop RTU Inj. (Irinotecan)
  • Closone Cap. (Clopidogrel + Aspirin)

    Product Closone Cap. (Clopidogrel + Aspirin)

    Fixed Dose Combination drug, indicated for Atherosclerosis, thromboembolism
  • Silenor Tab. (Doxepine)

    Product Silenor Tab. (Doxepine)

    Insomnia, Non-addictive and helps staying asleep longer